Pfizer’s stock has fallen 55% from its 2021 peak, pushing its dividend yield to 6.3%, far above the pharmaceutical sector average of 1.7%. While management has pledged to maintain the payout, high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results